• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺疾病中的肠道菌群失调:一个致病因素和一个新的治疗靶点。

Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target.

作者信息

Zhang Tao, Gao Guangqi, Sakandar Hafiz Arbab, Kwok Lai-Yu, Sun Zhihong

机构信息

Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot, China.

Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs, Inner Mongolia Agricultural University, Hohhot, China.

出版信息

Front Nutr. 2022 Feb 15;9:814269. doi: 10.3389/fnut.2022.814269. eCollection 2022.

DOI:10.3389/fnut.2022.814269
PMID:35242797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8885515/
Abstract

Pancreatic-related disorders such as pancreatitis, pancreatic cancer, and type 1 diabetes mellitus (T1DM) impose a substantial challenge to human health and wellbeing. Even though our understanding of the initiation and progression of pancreatic diseases has broadened over time, no effective therapeutics is yet available for these disorders. Mounting evidence suggests that gut dysbiosis is closely related to human health and disease, and pancreatic diseases are no exception. Now much effort is under way to explore the correlation and eventually potential causation between the gut microbiome and the course of pancreatic diseases, as well as to develop novel preventive and/or therapeutic strategies of targeted microbiome modulation by probiotics, prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation (FMT) for these multifactorial disorders. Attempts to dissect the intestinal microbial landscape and its metabolic profile might enable deep insight into a holistic picture of these complex conditions. This article aims to review the subtle yet intimate nexus loop between the gut microbiome and pancreatic diseases, with a particular focus on current evidence supporting the feasibility of preventing and controlling pancreatic diseases microbiome-based therapeutics and therapies.

摘要

胰腺炎、胰腺癌和1型糖尿病(T1DM)等胰腺相关疾病对人类健康和福祉构成了重大挑战。尽管随着时间的推移,我们对胰腺疾病的发生和发展的理解有所拓宽,但针对这些疾病仍没有有效的治疗方法。越来越多的证据表明,肠道微生物群失调与人类健康和疾病密切相关,胰腺疾病也不例外。目前正在进行大量研究,以探索肠道微生物群与胰腺疾病病程之间的相关性以及最终可能的因果关系,并开发通过益生菌、益生元、合生元、后生元以及粪便微生物群移植(FMT)对微生物群进行靶向调节的新型预防和/或治疗策略,用于治疗这些多因素疾病。剖析肠道微生物格局及其代谢谱的尝试可能有助于深入了解这些复杂病症的整体情况。本文旨在综述肠道微生物群与胰腺疾病之间微妙而紧密的联系,特别关注支持基于微生物群的治疗方法预防和控制胰腺疾病可行性的现有证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/2667e9cc69e8/fnut-09-814269-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/c4d53b98d682/fnut-09-814269-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/54c73db15548/fnut-09-814269-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/6c37a4d2934f/fnut-09-814269-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/3c70b395cb1d/fnut-09-814269-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/2667e9cc69e8/fnut-09-814269-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/c4d53b98d682/fnut-09-814269-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/54c73db15548/fnut-09-814269-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/6c37a4d2934f/fnut-09-814269-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/3c70b395cb1d/fnut-09-814269-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa68/8885515/2667e9cc69e8/fnut-09-814269-g0005.jpg

相似文献

1
Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target.胰腺疾病中的肠道菌群失调:一个致病因素和一个新的治疗靶点。
Front Nutr. 2022 Feb 15;9:814269. doi: 10.3389/fnut.2022.814269. eCollection 2022.
2
Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.益生菌、益生元、合生元和后生元对靶向肠道微生物群的代谢性疾病的影响和作用机制:一种叙述性综述。
Nutrients. 2021 Sep 15;13(9):3211. doi: 10.3390/nu13093211.
3
Gut microbiome-targeted therapies for Alzheimer's disease.针对阿尔茨海默病的肠道微生物组靶向治疗。
Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.
4
Unravelling the Role of Gut and Oral Microbiota in the Pediatric Population with Type 1 Diabetes Mellitus.揭开肠道和口腔微生物群在 1 型糖尿病患儿中的作用。
Int J Mol Sci. 2024 Oct 2;25(19):10611. doi: 10.3390/ijms251910611.
5
Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.胰腺癌与肠道微生物组相关方面:全面综述及饮食建议。
Nutrients. 2021 Dec 10;13(12):4425. doi: 10.3390/nu13124425.
6
Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.人类肠道微生物组:癌症诊断与治疗的新前沿。
Curr Pharm Des. 2021;27(45):4578-4592. doi: 10.2174/1381612827666211006152112.
7
Gut microbiome in acute pancreatitis: A review based on current literature.基于当前文献的综述:急性胰腺炎中的肠道微生物组
World J Gastroenterol. 2021 Aug 14;27(30):5019-5036. doi: 10.3748/wjg.v27.i30.5019.
8
Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review.肠道菌群失调与重度抑郁症关联的作用机制研究:一篇全面的综述。
Cells. 2022 Apr 16;11(8):1362. doi: 10.3390/cells11081362.
9
Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.结直肠癌治疗中肠道微生物组修饰的治疗方法 - 粪便微生物移植、益生元、益生菌和合生菌。
Gut Microbes. 2020 Nov 1;11(6):1518-1530. doi: 10.1080/19490976.2020.1764309. Epub 2020 May 26.
10
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives.过度喂养肠道微生物组:对健康影响和治疗观点的范围综述。
World J Gastroenterol. 2021 Nov 7;27(41):7041-7064. doi: 10.3748/wjg.v27.i41.7041.

引用本文的文献

1
The early-life gut microbiome in common pediatric diseases: roles and therapeutic implications.常见儿科疾病中的早期肠道微生物群:作用及治疗意义
Front Nutr. 2025 May 29;12:1597206. doi: 10.3389/fnut.2025.1597206. eCollection 2025.
2
A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer.一种用于胰腺癌个性化风险评估的血液代谢物特征
J Cancer Immunol (Wilmington). 2024;6(4):148-153. doi: 10.33696/cancerimmunol.6.095.
3
The close association of Muribaculum and PA (10:0/a-17:0) with the occurrence of pancreatic ductal adenocarcinoma and immunotherapy.

本文引用的文献

1
Chronic pancreatitis in a caerulein-induced mouse model is associated with an altered gut microbiome.在胆囊收缩素诱导的小鼠模型中,慢性胰腺炎与肠道微生物组的改变有关。
Pancreatology. 2022 Jan;22(1):30-42. doi: 10.1016/j.pan.2021.12.003. Epub 2021 Dec 16.
2
The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.肠道微生物组作为一种非侵入性的预测性生物标志物,用于早期检测胰腺癌和肝细胞癌的潜力。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7275-7284. doi: 10.26355/eurrev_202112_27421.
3
Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients.
穆里巴库菌与PA(10:0/a-17:0)与胰腺导管腺癌的发生及免疫治疗的密切关联。
Front Immunol. 2024 Nov 29;15:1505966. doi: 10.3389/fimmu.2024.1505966. eCollection 2024.
4
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications.肠道微生物代谢特征与糖尿病及其潜在的预防和治疗应用。
Gut Microbes. 2024 Jan-Dec;16(1):2401654. doi: 10.1080/19490976.2024.2401654. Epub 2024 Oct 18.
5
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders.微生物群和粪便微生物群移植在胰腺疾病中的重要性。
Diagnostics (Basel). 2024 Apr 23;14(9):861. doi: 10.3390/diagnostics14090861.
6
Exploring the Microbial Landscape: Gut Dysbiosis and Therapeutic Strategies in Pancreatitis-A Narrative Review.探索微生物景观:胰腺炎中的肠道菌群失调与治疗策略——一篇叙述性综述
Biomedicines. 2024 Mar 14;12(3):645. doi: 10.3390/biomedicines12030645.
7
Roles of microbiota in pancreatic cancer development and treatment.微生物群在胰腺癌发生和治疗中的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2320280. doi: 10.1080/19490976.2024.2320280. Epub 2024 Feb 27.
8
Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.胆胰和非胆胰胆管癌胆汁中的微生物特征。
PLoS One. 2024 Feb 21;19(2):e0294049. doi: 10.1371/journal.pone.0294049. eCollection 2024.
9
Use of probiotics and similar in pediatric patients with Type 1 Diabetes Mellitus: a systematic review.益生菌和类似物在 1 型糖尿病患儿中的应用:系统评价。
Rev Paul Pediatr. 2024 Feb 12;42:e2023097. doi: 10.1590/1984-0462/2024/42/2023097. eCollection 2024.
10
Microbiome as a biomarker and therapeutic target in pancreatic cancer.微生物组作为胰腺癌的生物标志物和治疗靶点。
BMC Microbiol. 2024 Jan 5;24(1):16. doi: 10.1186/s12866-023-03166-4.
肠道菌群改变及其与胰腺癌患者癌基因改变的关系。
Int J Mol Sci. 2021 Nov 30;22(23):12978. doi: 10.3390/ijms222312978.
4
Tuning gut microbiota through a probiotic blend in gemcitabine-treated pancreatic cancer xenografted mice.在吉西他滨治疗的胰腺癌异种移植小鼠中通过益生菌混合物调节肠道微生物群。
Clin Transl Med. 2021 Nov;11(11):e580. doi: 10.1002/ctm2.580.
5
Improvement of Cutaneous Wound Healing via Topical Application of Heat-Killed CAU 1447 on Diabetic Mice.经皮应用热灭活 CAU1447 促进糖尿病小鼠创面愈合。
Nutrients. 2021 Jul 31;13(8):2666. doi: 10.3390/nu13082666.
6
Type 1 diabetes in pregnancy is associated with distinct changes in the composition and function of the gut microbiome.妊娠期1型糖尿病与肠道微生物群的组成和功能的明显变化有关。
Microbiome. 2021 Aug 6;9(1):167. doi: 10.1186/s40168-021-01104-y.
7
The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer.微生物群作为胰腺癌治疗性干预的潜在靶点
Cancers (Basel). 2021 Jul 27;13(15):3779. doi: 10.3390/cancers13153779.
8
Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice.母体盲肠微生物群转移可挽救早期生活抗生素诱导的小鼠 1 型糖尿病增强。
Cell Host Microbe. 2021 Aug 11;29(8):1249-1265.e9. doi: 10.1016/j.chom.2021.06.014. Epub 2021 Jul 21.
9
A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study.高剂量多菌株益生菌改善新发 1 型糖尿病儿童的血糖控制:一项随机、双盲、安慰剂对照的初步研究。
Pediatr Diabetes. 2021 Nov;22(7):1014-1022. doi: 10.1111/pedi.13244. Epub 2021 Jul 3.
10
Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice.肠道微生物群中乙酸产生菌的耗竭通过糖尿病小鼠的肠-脑神经机制促进认知障碍。
Microbiome. 2021 Jun 25;9(1):145. doi: 10.1186/s40168-021-01088-9.